Ye Liu, MD, MPH

University of Alabama at Birmingham
Birmingham, AL, United States

Have been working in academic clinical settings for more than 10 years

Presentation(s):

• 1620: Cardiovascular Risk and Fracture Risk Among Women Initiating Treatment with Romosozumab or Denosumab

  Monday, November 13, 2023
  3:15 PM – 3:25 PM PT

  Disclosure information not submitted.

• 1818: Compliance with Romosozumab and Fracture Risk Among Postmenopausal Women in the U.S

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.